Innovotech (CVE:IOT) Trading Down 41% – What’s Next?

Innovotech Inc. (CVE:IOTGet Free Report) fell 41% on Wednesday . The company traded as low as C$0.11 and last traded at C$0.12. 591,310 shares changed hands during trading, an increase of 1,389% from the average session volume of 39,725 shares. The stock had previously closed at C$0.20.

Innovotech Stock Performance

The stock has a 50-day simple moving average of C$0.19 and a 200-day simple moving average of C$0.23. The company has a market capitalization of C$6.53 million, a price-to-earnings ratio of 65.04 and a beta of 2.86. The company has a current ratio of 2.63, a quick ratio of 5.81 and a debt-to-equity ratio of 12.55.

About Innovotech

(Get Free Report)

Innovotech Inc provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; MBEC Assay kit, a petri dish for biofilms, which are used for research and medical device testing of microbial biofilms; and AgreGuard, an antimicrobial for crop protection. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices; bacteriophage testing; and analytical services.

Featured Articles

Receive News & Ratings for Innovotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovotech and related companies with MarketBeat.com's FREE daily email newsletter.